TMPs inject methotrexate into cholangiocarcinoma cells (CCA), induce GSDME-mediated pyroptosis, activate patient-derived macrophages to produce pro-inflammatory cytokines, and recruit neutrophils to tumor sites for performing drug-directed tumor destruction81. Here, GSDME is linked to cholangiocarcinoma.